Leukemia Drug Stimulates Immunity Against Many Cancer Types

the ONA take:

A new study reports that p110δ inhibitors, a class of drugs used to treat leukemia, have an unexpected benefit. They boost immune responses against many different cancers. The researchers at University College London, the Babraham Institute and Queen Mary University of London, with scientists fromGenentech, South San Francisco, showed that inhibiting p110δ in mice significantly increased cancer survival rates across a broad range of solid and hematological cancers. The team’s data further show that following p110δ inhibition, the immune system could develop an effective memory response to completely fight off the cancer.

Leukemia Drug Stimulates Immunity Against Many Cancer Types
Leukemia Drug Stimulates Immunity Against Many Cancer Types
A class of drug currently being used to treat leukemia has the unexpected side-effect of boosting immune responses against many different cancers, reports a new study. The drugs, called p110 inhibitors, have shown such remarkable efficacy against certain leukemias in recent clinical trials that ...
READ FULL ARTICLE From Goodnewsnetwork
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs